Kodiak Sciences (KOD) Non-Current Deferred Tax Liability (2021)
Kodiak Sciences (KOD) posted Non-Current Deferred Tax Liability of $350000.0 for Q4 2021.
Kodiak Sciences (KOD) Non-Current Deferred Tax Liability (2021) Analysis & Trends
Kodiak Sciences' Non-Current Deferred Tax Liability history runs 1 years deep, the most recent figure standing at $350000.0 for Q4 2021.
- Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $350000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $350000.0 (changed N/A YoY) and the FY2021 annual result came in at $350000.0, changed N/A from the prior year.
- Non-Current Deferred Tax Liability was $350000.0 for Q4 2021 at Kodiak Sciences.
- Across five years, Non-Current Deferred Tax Liability topped out at $350000.0 in Q4 2021 and bottomed at $350000.0 in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Kodiak Sciences | 2.54 Bn | 2.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 350,000.00 |
| Dec 31, 2021 | 350,000.00 |